Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Zheng Zeng, Dan Yang, Xiaoling Huang & Zhenliang Xiao. (2017) Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2277-2283.
Read now
Read now
Kara Johnson, Charlene E McEvoy, Sakina Naqvi, Chris Wendt, Ronald A Reilkoff, Ken M Kunisaki, Erin E Wetherbee, David Nelson, Rabindra Tirouvanziam & Dennis E Niewoehner. (2016) High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 799-807.
Read now
Read now
Jia-Qiang Zhang, Jian-Qing Zhang, Li-Zhou Fang, Ling Liu, Wei-Ping Fu & Lu-Ming Dai. (2015) Effect of oral N-acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter. Drug Design, Development and Therapy 9, pages 6379-6387.
Read now
Read now
Jian-Qing Zhang, Jia-Qiang Zhang, Hua Liu, Zhi-Huan Zhao, Li-Zhou Fang, Ling Liu, Wei-Ping Fu, Jing-Kui Shu, Jia-Gang Feng & Lu-Ming Dai. (2015) Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 917-923.
Read now
Read now
Pierachille Santus, Angelo Corsico, Paolo Solidoro, Fulvio Braido, Fabiano Di Marco & Nicola Scichilone. (2014) Oxidative Stress and Respiratory System: Pharmacological and Clinical Reappraisal of N-Acetylcysteine. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:6, pages 705-717.
Read now
Read now
Yanfei Shen, Wanru Cai, Shu Lei & Zhongheng Zhang. (2014) Effect of High/Low Dose N-Acetylcysteine on Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:3, pages 351-358.
Read now
Read now
Michael E. Nicks, Maureen M. O'Brien & Russell P. Bowler. (2011) Plasma Antioxidants Are Associated with Impaired Lung Function and COPD Exacerbations in Smokers. COPD: Journal of Chronic Obstructive Pulmonary Disease 8:4, pages 264-269.
Read now
Read now
Jiun-Lih Lin & Paul S. Thomas. (2010) Current Perspectives of Oxidative Stress and its Measurement in Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 7:4, pages 291-306.
Read now
Read now
Noora Louhelainen, Marjukka Myllärniemi, Irfan Rahman & Vuokko L Kinnula. (2008) Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: Current and future perspectives. International Journal of Chronic Obstructive Pulmonary Disease 3:4, pages 585-603.
Read now
Read now
Articles from other publishers (25)
T. V. Tayutina. (2023) An integrated approach to the implementation of the stage of pulmonary rehabilitation of patients with chronic obstructive pulmonary disease: the importance of lifestyle modification. The Clinician 17:1, pages 28-38.
Crossref
Crossref
Chienhsiu Huang, Sufang Kuo, Lichen Lin & Yalun Yang. (2023)
The efficacy of
N
-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis
. Therapeutic Advances in Respiratory Disease 17, pages 175346662311585.
Crossref
Crossref
Yong Seok Jo, Ick Soo Choi & Yoon Kyoung So. (2021) The Use of Inhaled N-Acetylcysteine for Laryngopharyngeal Reflux Disease: A Randomized Controlled Trial. Journal of Voice 35:4, pages 618-624.
Crossref
Crossref
Hidehiro Irie, Shotaro Chubachi, Minako Sato, Mamoru Sasaki, Naofumi Kameyama, Takashi Inoue, Yoshitaka Oyamada, Hidetoshi Nakamura, Koichiro Asano & Tomoko Betsuyaku. (2017) Impact of cataract on health-related quality of life in a longitudinal Japanese chronic obstructive pulmonary cohort. Chronic Respiratory Disease 15:4, pages 329-338.
Crossref
Crossref
. (2017) Tratamiento de la EPOC Estable. Archivos de Bronconeumología 53, pages 23-33.
Crossref
Crossref
Claudio M. Sanguinetti. (2016) N-acetylcysteine in COPD: why, how, and when?. Multidisciplinary Respiratory Medicine 11:1.
Crossref
Crossref
Katharina Kranzer, Wael F Elamin, Helen Cox, James A Seddon, Nathan Ford & Francis Drobniewski. (2015)
A systematic review and meta-analysis of the efficacy and safety of
N
-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB
. Thorax 70:11, pages 1070-1077.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Clive Page, Josè Jardim, Alexander G. Chuchalin, Paola Rogliani & Maria Gabriella Matera. (2015)
Influence of
N
-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
. European Respiratory Review 24:137, pages 451-461.
Crossref
Crossref
Zeynep Ayfer Aytemur, Aysegul Baysak, Ozer Ozdemir, Timur Köse & Abdullah Sayiner. (2015) N-acetylcysteine in patients with COPD exacerbations associated with increased sputumN-Acetylcystein bei Patienten mit Exazerbation einer COPD mit erhöhter Sputumproduktion. Wiener klinische Wochenschrift 127:7-8, pages 256-261.
Crossref
Crossref
Mario Cazzola & Maria Gabriella Matera. (2014) N-acetylcysteine in COPD may be beneficial, but for whom?. The Lancet Respiratory Medicine 2:3, pages 166-167.
Crossref
Crossref
Qi Zhang, Jiun-Lih Lin & Paul S. Thomas. 2014. Systems Biology of Free Radicals and Antioxidants. Systems Biology of Free Radicals and Antioxidants
1643
1670
.
Thomas E. Sussan & Shyam Biswal. 2014. Studies on Respiratory Disorders. Studies on Respiratory Disorders
335
348
.
Ahmed Mahmoud Abd El Hafiz, Lamia Mohammed El Wakeel, Hend Mohammed El Hady & Abd El Raheem Mourad. (2013) High dose N-acetyl cysteine improves inflammatory response and outcome in patients with COPD exacerbations. Egyptian Journal of Chest Diseases and Tuberculosis 62:1, pages 51-57.
Crossref
Crossref
. (2012) Anexo 2 Preguntas respondidas por la UETS en la GPC para el tratamiento de pacientes con EPOC. Archivos de Bronconeumología 48, pages 61-80.
Crossref
Crossref
. (2012) Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC) - Guía Española de la EPOC (GesEPOC). Archivos de Bronconeumología 48, pages 2-58.
Crossref
Crossref
Istvan Szelenyi. (2011) Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases. Inflammation Research 61:1, pages 1-9.
Crossref
Crossref
Shiwan K. Shah, Shawn P. E. Nishi & Gulshan Sharma. 2012. Aging and Lung Disease. Aging and Lung Disease
63
87
.
Timothy E. Albertson, Kelly P. Owen, Mark E. Sutter & Nicholas J. Kenyon. 2012. Bronchial Asthma. Bronchial Asthma
361
381
.
A. Cuvelier, D. Benhamou, B. Lamia & J.-F. Muir. (2010) Exacerbations de la bronchopneumopathie chronique obstructive. EMC - Pneumologie 7:2, pages 1-17.
Crossref
Crossref
Tiffany R. Richens, Derek J. Linderman, Sarah A. Horstmann, Cherie Lambert, Yi-Qun Xiao, Robert L. Keith, Darren M. Boé, Konosuke Morimoto, Russell P. Bowler, Brian J. Day, William J. Janssen, Peter M. Henson & R. William Vandivier. (2009) Cigarette Smoke Impairs Clearance of Apoptotic Cells through Oxidant-dependent Activation of RhoA. American Journal of Respiratory and Critical Care Medicine 179:11, pages 1011-1021.
Crossref
Crossref
I. V. Leshchenko. (2008) Drug therapy of stable chronic obstructive pulmonary disease. PULMONOLOGIYA:3, pages 73-82.
Crossref
Crossref
Rivka Siden & Cary E. Johnson. (2008) Stability of a flavored formulation of acetylcysteine for oral administration. American Journal of Health-System Pharmacy 65:6, pages 558-561.
Crossref
Crossref
Katri KoliMarjukka MyllärniemiJorma Keski-OjaVuokko L. Kinnula. (2008)
Transforming Growth Factor-
β
Activation in the Lung: Focus on Fibrosis and Reactive Oxygen Species
. Antioxidants & Redox Signaling 10:2, pages 333-342.
Crossref
Crossref
Nicola A. Hanania & Amir Sharafkhaneh. (2007) Update on the Pharmacologic Therapy for Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 28:3, pages 589-607.
Crossref
Crossref
S. N. Avdeev. (2007) Reduction of exacerbations of COPD under long-term administration of N-acetylcysteine. PULMONOLOGIYA:2, pages 89-97.
Crossref
Crossref